Skip to content

PHARMA IMPEX

Active
Private limited companyfounded 20215 yrs activeChaussée de Bruxelles(MEL) 101, 6211 Les Bons Villers, BelgiumKBO/BCE: BE 0763.508.477

The computed 12-month bankruptcy probability of PHARMA IMPEX is 4.7% (elevated). The 2024 annual accounts show negative equity (€-13k) and a net result of €-3k. Equity is shrinking by ~82.5% per year across the filed fiscal years. Its solvency ranks better than 8% of 26046 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
13 / 100
Critical
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0=
Solvency0=
Growth32=
Track record94
Bankruptcy probability, 12 months
4.7% Elevated
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.41 against 0.59 in 2023; short-term debt: 242.4% and cash: 0.4% of total assets), and equity is negative.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
-142.4%
Return on assets
-34.9%
Age of the figures
21 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 5 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
21222324
2021 to 2024 · latest year €-13k
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 25-08-2025, 25 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
25 d late
2023
28 d late
2022
46 d late
2021
23 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€-13k▼ 32.5%
2023 · €-10k
2021: €3k 2022: €-4k 2023: €-10k
2021 → 2024
Total assets
€9k▼ 35.8%
2023 · €14k
2021: €17k 2022: €8k 2023: €14k
2021 → 2024
Net result
€-3k▲ 46.0%
2023 · €-6k
2021: €1k 2022: €-7k 2023: €-6k
2021 → 2024
Working capital
€-13k▼ 32.5%
2023 · €-10k
2021: €3k 2022: €-4k 2023: €-10k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line2021202220232024Trend
Equity€3k-€-4k€-10k▼ 151%€-13k▼ 32.5%
Operating result€2k-€-7k€-6k▲ 20.7%€-3k▲ 45.4%
Net result€1k-€-7k€-6k▲ 17.3%€-3k▲ 46.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-8k€-5k€-3k€0€3kOperating result 2021: €2k€2kNet result 2021: €1k€1kOperating result 2022: €-7k€-7kNet result 2022: €-7k€-7kOperating result 2023: €-6k€-6kNet result 2023: €-6k€-6kOperating result 2024: €-3k€-3kNet result 2024: €-3k€-3k2021202220232024
The operating result stays negative: a loss of €3k in 2024 against €6k in 2023; the loss shrinks.
Key figures and ratios
2024 value · change against 2023
Solvency
-142.4%
2023 · -69.0%
Current ratio
0.41
2023 · 0.59
Quick ratio
0.29
2023 · 0.48
Debt / equity
-1.70
2023 · -2.45
ROA
-34.9%
2023 · -41.5%
Debt
€22k
2023 · €24k
Debt ≤ 1 year
€22k
2023 · €24k
Income taxes
€0
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€14k€9k
Current assets29/58€14k€9k
Stocks and contracts in progress3€3k€3k=
Stocks30/36€3k€3k=
Amounts receivable within one year40/41€11k€6k
Trade receivables40€11k€6k
Other amounts receivable41-€144
Cash at bank and in hand54/58€679€33
Equity and liabilities
Total equity and liabilities10/49€14k€9k
Equity10/15€-10k€-13k
Contributions10/11€2k€2k=
Reserves13€1k€1k=
Distributable reserves133€1k€1k=
Profit (loss) carried forward14€-13k€-16k
Amounts payable17/49€24k€22k
Amounts payable within one year42/48€24k€22k
Trade debts44€15k€6k
Suppliers440/4€15k€6k
Advances received on contracts in progress46-€7k
Taxes, remuneration and social security45€1k-
Taxes450/3€1k-
Other amounts payable47/48€8k€9k
Income statement Code20232024
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€3k€-3k
Other operating charges640/8-€387
Gross operating margin9900€-3k€-6k
Operating profit (loss)9901€-6k€-3k
Financial income75/76B€0€0
Recurring financial income75€0€0
Financial charges65/66B€347€153
Recurring financial charges65€347€153
Profit (loss) for the period before taxes9903€-6k€-3k
Income taxes67/77-€0
Profit (loss) for the period9904€-6k€-3k
Profit (loss) for the period to be appropriated9905€-6k€-3k
Appropriation of the result
Profit (loss) to be appropriated9906€-13k€-16k
Profit (loss) brought forward from the previous period14P€-7k€-13k

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
25-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 25 days late
2024
28-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 28 days late
2023
15-09
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 46 days late
2022
31-12
Financial Weakest financial yearnet €-7k ▼672%
Net result drops to €-7k, the lowest in the series; recovery starts the following year.
23-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Les Bons Villers · 1 establishment unit since 2021
establishment approximate The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Chaussée de Bruxelles(MEL) 1016211 Les Bons Villers
Ground area
6,413 m²
Building footprint
221 m²
Volume, LiDAR
632 m³
2 parcels, Wallonia · tallest building 6.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Pharma Impex
Chaussée de Bruxelles(FLG) 101, 6210 Les Bons VillersWholesale trade
since 20212.314.037.542
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52024B0018/00D002 Wallonia 4,281 m² 1 · 90 m² -
52046B0075/00F000 Wallonia 2,132 m² 1 · 130 m² 6.1 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,070 companies in sector 47741 we hold annual accounts for 644. 141 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded11-02-2021
Fiscal year end31-12
Activities, NACEBEL
46180Agents specialised in the wholesale of other particular products
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
46649Wholesale of other machinery and equipment
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.